Original Article

You have full text access to this OnlineOpen article

Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508†

  1. Joseph I. Clark MD1,‡,*,
  2. James Moon MS2,
  3. Laura F. Hutchins MD3,
  4. Jeffrey A. Sosman MD4,
  5. W. Martin Kast PhD5,
  6. Diane M. Da Silva PhD5,
  7. P. Y. Liu PhD2,
  8. John A. Thompson MD6,
  9. Lawrence E. Flaherty MD7,
  10. Vernon K. Sondak MD8

Article first published online: 13 NOV 2009

DOI: 10.1002/cncr.24739

Issue

Cancer

Cancer

Volume 116, Issue 2, pages 424–431, 15 January 2010

Additional Information

How to Cite

Clark, J. I., Moon, J., Hutchins, L. F., Sosman, J. A., Kast, W. M., Da Silva, D. M., Liu, P. Y., Thompson, J. A., Flaherty, L. E. and Sondak, V. K. (2010), Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508. Cancer, 116: 424–431. doi: 10.1002/cncr.24739

Author Information

  1. 1

    Loyola University Stritch School of Medicine, Maywood, Illinois

  2. 2

    Southwest Oncology Group Statistical Center, Seattle, Washington

  3. 3

    University of Arkansas for Medical Sciences, Little Rock, Arkansas

  4. 4

    Vanderbilt University School of Medicine, Nashville, Tennessee

  5. 5

    University of Southern California, Los Angeles, California

  6. 6

    Seattle Cancer Care Alliance, Seattle, Washington

  7. 7

    Wayne State University, Detroit, Michigan

  8. 8

    H. Lee Moffitt Cancer Center, Tampa, Florida

  1. ‡

    Fax: (708) 327-3218

*Cardinal Bernardin Cancer Center, Loyola University Medical Center, Division of Hematology/Oncology, 2160 South First Avenue, Maywood, IL 60153

  1. †

    Presented at the American Society of Clinical Oncology (ASCO) 44th Annual Meeting , May 30–June 3, 2008, Chicago, Illinois.

Publication History

  1. Issue published online: 20 JAN 2010
  2. Article first published online: 13 NOV 2009
  3. Manuscript Accepted: 4 MAY 2009
  4. Manuscript Revised: 16 APR 2009
  5. Manuscript Received: 6 FEB 2009

Funded by

  • National Cancer Institute, DHHS. Grant Numbers: CA32102, CA38926, CA46282, CA20319, CA22433, CA35178, CA45807, CA35261, CA35176, CA35431, CA37981, CA74647, CA45808, CA58861, CA45461, CA04919, CA58416, CA67575, CA45560, CA76426, CA11083
  • Celgene Corporation

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (146K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Guadalupe Palencia, Carmen Rubio, Veronica Custodio-Ramirez, Carlos Paz, Julio Sotelo, Strong anticonvulsant effect of thalidomide on amygdaloid kindling, Epilepsy Research, 2011, 95, 3, 263

    CrossRef

  2. 2
    Wen-Jen Hwu, Robert D. Knight, Madhavi Patnana, Roland Bassett, Nicholas E. Papadopoulos, Kevin B. Kim, Patrick Hwu, Agop Bedikian, Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapy, Melanoma Research, 2010, 20, 6, 501

    CrossRef

View Full Article (HTML) Get PDF (146K)